Results 241 to 250 of about 6,855,013 (350)
Tumor mutational burden as a determinant of metastatic dissemination patterns
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal +4 more
wiley +1 more source
Validation and measurement invariance of the Alcohol-Induced Blackout Measure-2 among noncollege young adults. [PDF]
Strowger M +6 more
europepmc +1 more source
Unintended consequences of EU external action [PDF]
Burlyuk, Olga, Noutcheva, Gergana
core +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Consequences and Coping Strategies Following Exposure to Obstetric Violence Among Maternity Healthcare Professionals. [PDF]
Sharon D, Alnabilsy R.
europepmc +1 more source
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source
Family Medicine Residency Match Is Not a "Field of Dreams". [PDF]
Stickler M, Shaver WM, Franks AM.
europepmc +1 more source

